Individualizing immunosuppression in lung transplantation

Immunosuppression management after lung transplantation continues to evolve, with an increasing number of agents available for use in various combinations allowing for more choice and individualization of immunosuppressive therapy. Therapeutic developments have led to improved outcomes including low...

Descripción completa

Detalles Bibliográficos
Autores principales: McDermott, Jennifer K., Girgis, Reda E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857067/
https://www.ncbi.nlm.nih.gov/pubmed/29644232
http://dx.doi.org/10.21542/gcsp.2018.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857067/
https://www.ncbi.nlm.nih.gov/pubmed/29644232
http://dx.doi.org/10.21542/gcsp.2018.5

Ejemplares similares